Is Travere Therapeutics, Inc. (TVTX) a Buy, Sell, or Hold?
NASDAQ : TVTX
Travere Therapeutics, Inc. — Institutional Ownership
$55.89 USD
-$1.39 (-2.43%)
- Volume
- 1.5M
- Average Volume
- 2.08M
- Market Capitalization
- $5.2B
- P/E Ratio
- -114.06
- Dividend Yield
- 0.00%
- Price Target
- $65.00
- Year High
- $60.10
- Year Low
- $15.42
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.13
Institutional Ownership Summary
Institutional Ownership %
4.49%
Investors Holding
53
change: -226 | last: 279
Increased Positions
34
change: -107 | last: 141
Reduced Positions
12
change: -82 | last: 94
New Positions
18
change: -30 | last: 48
Sold Positions
228
change: 159 | last: 69
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -71.8215 | last: 0.7182
Total Invested
234.78M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-15 | Armistice Capital, LLC | 4.9M | 5.27% |
| 2026-04-30 | Vanguard Capital Management | 4.7M | 5.09% |
| 2026-03-27 | The Vanguard Group | - | 0.00% |
| 2026-02-17 | Armistice Capital, LLC | 3.76M | 4.21% |
| 2026-02-17 | Perceptive Advisors LLC | 4.28M | 4.80% |
| 2026-02-13 | Macquarie Group Limited | - | 0.00% |
| 2026-02-09 | STATE STREET CORPORATION | 4.76M | 5.30% |
| 2026-01-08 | FMR LLC | 10.57M | 11.70% |
| 2025-11-14 | Armistice Capital, LLC | 6.72M | 7.52% |
| 2025-11-14 | JANUS HENDERSON GROUP PLC | 10.6M | 11.90% |
| 2025-10-14 | Perceptive Advisors LLC | 4.9M | 5.50% |
| 2025-08-15 | Armistice Capital, LLC | 8.88M | 9.96% |
| 2025-08-07 | JANUS HENDERSON GROUP PLC | 11.34M | 12.80% |
| 2025-07-29 | The Vanguard Group | 5.99M | 6.74% |
| 2025-05-15 | Rock Springs Capital Management LP | 2.92M | 3.30% |
| 2025-05-15 | Macquarie Group Limited | 4.8M | 5.41% |
| 2025-05-15 | Armistice Capital, LLC | 8.87M | 9.99% |
| 2025-05-14 | JANUS HENDERSON GROUP PLC | 7.57M | 8.50% |
| 2025-04-30 | The Vanguard Group | 5.01M | 5.65% |
| 2025-04-17 | BlackRock, Inc. | 6.69M | 7.50% |
| 2025-02-14 | Woodline Partners LP | 2.11M | 2.40% |
| 2025-02-14 | Armistice Capital, LLC | 7.36M | 9.62% |
| 2025-02-14 | Rock Springs Capital Management LP | 4.97M | 5.72% |
| 2025-02-07 | Macquarie Group Limited | 4.26M | 4.90% |
| 2025-02-05 | BlackRock, Inc. | 8.02M | 9.40% |
| 2025-01-31 | The Vanguard Group | 6.74M | 7.75% |
| 2024-11-14 | Woodline Partners LP | 4.34M | 5.70% |
| 2024-05-01 | Rock Springs Capital Management LP | 4.41M | 5.79% |
| 2024-02-09 | Morgan Stanley | 4.15M | 5.50% |
| 2023-03-13 | Robert Atchinson | 4.42M | 5.94% |
| 2023-03-13 | Adage Capital Advisors, L.L.C. | 4.42M | 5.94% |
| 2023-03-13 | Adage Capital Partners, L.P. | 4.42M | 5.94% |
| 2023-03-13 | Phillip Gross | 4.42M | 5.94% |
| 2023-03-13 | Adage Capital Partners GP, L.L.C. | 4.42M | 5.94% |
| 2023-02-06 | STATE STREET CORPORATION | 4.22M | 6.58% |
| 2022-10-28 | Adage Capital Advisors, L.L.C. | 3.93M | 6.14% |
| 2022-10-28 | Adage Capital Partners GP, L.L.C. | 3.93M | 6.14% |
| 2022-10-28 | Phillip Gross | 3.93M | 6.14% |
| 2022-10-28 | Robert Atchinson | 3.93M | 6.14% |
| 2022-10-28 | Adage Capital Partners, L.P. | 3.93M | 6.14% |
| 2022-05-16 | David Kroin | 3.44M | 5.41% |
| 2022-05-16 | Deep Track Biotechnology Master Fund, Ltd. | 3.44M | 5.41% |
| 2022-05-16 | Deep Track Capital, LP | 3.44M | 5.41% |
| 2022-02-14 | Armistice Capital, LLC | 4.08M | 6.70% |
| 2022-02-14 | Steven Boyd | 4.08M | 6.70% |
| 2022-02-14 | ☐ | 1632.0 | 0.00% |
| 2022-02-14 | 10. | 3.77M | 6.15% |
| 2022-02-14 | 10. | 3.77M | 6.15% |
| 2022-02-14 | 10. | 3.77M | 6.15% |
| 2022-02-10 | EIN #00-0000000 | 4.02M | 6.60% |
| 2022-02-01 | THE GOLDMAN SACHS GROUP, INC. | 4.6M | 7.50% |
| 2022-02-01 | GOLDMAN SACHS & CO. LLC | 4.6M | 7.50% |
| 2021-08-13 | David Kroin | 3.09M | 5.09% |
| 2021-08-13 | Deep Track Biotechnology Master Fund, Ltd. | 3.09M | 5.09% |
| 2021-08-13 | Deep Track Capital, LP | 3.09M | 5.09% |
| 2021-02-16 | 10 | 3.49M | 6.80% |
| 2021-02-16 | 10 | 3.49M | 6.80% |
| 2021-02-12 | ☐ | 1562.0 | 0.00% |
| 2021-02-12 | 10. | 2.76M | 5.41% |
| 2021-02-12 | 10. | 2.76M | 5.41% |
| 2021-02-12 | EIN #00-0000000 | 4.08M | 8.00% |
| 2021-02-12 | 10. | 2.76M | 5.41% |
| 2021-02-12 | 10. | 2.76M | 5.41% |
| 2021-02-11 | Integrated Core Strategies (US) LLC | 708.78K | 1.40% |
| 2021-02-11 | Millennium International Management LP | 18396.0 | 0.00% |
| 2021-02-11 | ICS Opportunities, Ltd. | 6512.0 | 0.00% |
| 2021-02-11 | ICS Opportunities II LLC | 11153.0 | 0.00% |
| 2021-02-11 | Integrated Assets, Ltd. | 731.0 | 0.00% |
| 2021-02-11 | Millennium Group Management LLC | 727.18K | 1.40% |
| 2021-02-11 | Israel A. Englander | 727.18K | 1.40% |
| 2021-02-11 | Millennium Management LLC | 727.18K | 1.40% |
| 2021-02-01 | (1) BlackRock, Inc. | 4.83M | 9.50% |
| 2021-01-04 | Adage Capital Advisors, L.L.C. | 2.85M | 5.58% |
| 2021-01-04 | Robert Atchinson | 2.85M | 5.58% |
| 2021-01-04 | Phillip Gross | 2.85M | 5.58% |
| 2021-01-04 | Adage Capital Partners GP, L.L.C. | 2.85M | 5.58% |
| 2021-01-04 | Adage Capital Partners, L.P. | 2.85M | 5.58% |
| 2020-02-14 | Rajeev Shah | 4.25M | 9.90% |
| 2020-02-14 | Peter Kolchinsky | 4.25M | 9.90% |
| 2020-02-14 | RA Capital Management, L.P. | 4.25M | 9.90% |
| 2020-02-14 | Perceptive Life Sciences Master Fund, Ltd. | 2.89M | 6.70% |
| 2020-02-14 | Joseph Edelman | 2.89M | 6.70% |
| 2020-02-14 | Perceptive Advisors LLC | 2.89M | 6.70% |
| 2020-02-12 | Manulife Financial Corporation | - | 0.00% |
| 2020-02-11 | The Vanguard Group - 23-1945930 | 2.52M | 5.87% |
| 2020-01-28 | Millennium Group Management LLC | 2.22M | 5.20% |
| 2020-01-28 | Integrated Core Strategies (US) LLC | 2.22M | 5.20% |
| 2020-01-28 | Israel A. Englander | 2.22M | 5.20% |
| 2020-01-28 | Millennium International Management LP | 2057.0 | 0.00% |
| 2020-01-28 | Millennium Management LLC | 2.22M | 5.20% |
| 2020-01-28 | Integrated Assets, Ltd. | 2057.0 | 0.00% |
| 2020-01-10 | (1) BlackRock, Inc. | 4.34M | 10.10% |
| 2019-07-19 | Kevin Kotler | 2.08M | 5.01% |
| 2019-07-19 | Broadfin Capital, LLC | 2.08M | 5.01% |
| 2019-07-19 | Broadfin Healthcare Master Fund, Ltd. | 2.08M | 5.01% |
| 2019-02-14 | Consonance Capital Opportunity Fund Management LP | 112.95K | 0.27% |
| 2019-02-14 | 8.0% | 3.32M | 8.00% |
| 2019-02-14 | 10 | 3.4M | 8.20% |
| 2019-02-14 | 10 | 3.4M | 8.20% |
| 2019-02-14 | Mitchell Blutt | 4.03M | 9.78% |
| 2019-02-14 | Consonance Capital Management LP | 3.92M | 9.50% |
| 2019-02-14 | Consonance Capman GP LLC | 4.03M | 9.78% |
| 2019-02-11 | (1) BlackRock, Inc. | 3.63M | 8.80% |
| 2018-01-23 | (1) BlackRock, Inc. | 3.32M | 8.50% |
| 2017-02-14 | 10. | 5.1M | 13.50% |
| 2017-02-14 | 10. | 5.09M | 13.50% |
| 2017-02-14 | 10. | 5.09M | 13.50% |
| 2017-02-14 | 10. | 5.09M | 13.50% |
| 2017-02-10 | Broadfin Capital, LLC | 3.49M | 9.20% |
| 2017-02-10 | Broadfin Healthcare Master Fund, Ltd. | 3.49M | 9.20% |
| 2017-02-10 | Kevin Kotler | 3.49M | 9.20% |
| 2017-01-25 | (1) BlackRock, Inc. | 2.83M | 7.50% |
| 2016-07-11 | 10. | 3.81M | 10.40% |
| 2016-07-11 | 10. | 3.81M | 10.40% |
| 2016-07-11 | 10. | 3.82M | 10.40% |
| 2016-07-11 | 10. | 3.81M | 10.40% |
| 2016-03-31 | Matthew Sirovich | 3.61M | 9.88% |
| 2016-03-31 | Scopia Capital GP LLC | 3.6M | 9.86% |
| 2016-03-31 | Scopia Capital Management LP | 3.6M | 9.86% |
| 2016-03-31 | Scopia Management, Inc. | 3.6M | 9.86% |
| 2016-03-31 | PERSONS: Scopia Windmill Fund LP | 1.89M | 5.18% |
| 2016-03-31 | Jeremy Mindich | 3.6M | 9.86% |
| 2016-02-16 | Lombard Odier Asset Management (USA) Corp | 1.14M | 3.17% |
| 2016-02-11 | 2. | 229.75K | 0.63% |
| 2016-02-11 | 2. | 229.75K | 0.63% |
| 2016-02-11 | 2. | 178.86K | 0.49% |
| 2016-02-11 | 2. | 229.75K | 0.63% |
| 2016-02-09 | GOLDMAN, SACHS & CO. | 1.95M | 5.40% |
| 2016-02-09 | THE GOLDMAN SACHS GROUP, INC. | 1.95M | 5.40% |
| 2016-01-28 | (1) BlackRock, Inc. | 2.32M | 6.40% |
| 2015-02-17 | 2. | 2.05M | 7.47% |
| 2015-02-17 | Consonance Capman GP LLC | 2.55M | 9.60% |
| 2015-02-17 | 2. | 2.05M | 7.47% |
| 2015-02-17 | 2. | 2.05M | 7.47% |
| 2015-02-17 | 2. | 1.61M | 5.89% |
| 2015-02-17 | Consonance Capital Management LP | 2.5M | 9.40% |
| 2015-02-17 | Mitchell Blutt | 2.55M | 9.60% |
| 2015-02-17 | Consonance Capital Opportunity Fund Management LP | 51348.0 | 0.20% |
| 2015-02-11 | Lombard Odier Asset Management (USA) Corp | 1.75M | 6.62% |
| 2014-05-07 | Identification #52-2069785 (formerly 13-2631108) | 2.6M | 11.00% |
| 2014-02-10 | Identification #52-2069785 (formerly 13-2631108) | 1.05M | 11.00% |
| 2014-01-17 | Steven A. Cohen | 1.29M | 5.60% |
| 2014-01-17 | Kevin Kotler | 1.61M | 6.93% |
| 2014-01-17 | Sigma Capital Management, LLC | 315K | 1.40% |
| 2014-01-17 | S.A.C. Capital Advisors, Inc. | 976.47K | 4.20% |
| 2014-01-17 | Broadfin Capital, LLC | 1.61M | 6.93% |
| 2014-01-17 | S.A.C. Capital Advisors, L.P. | 976.47K | 4.20% |
| 2014-01-17 | Broadfin Healthcare Master Fund, Ltd. | 1.61M | 6.93% |
| 2013-08-26 | QVT Associates GP LLC | 1.68M | 9.20% |
| 2013-08-26 | QVT Financial GP LLC | 1.68M | 9.20% |
| 2013-08-26 | QVT Financial LP | 1.68M | 9.20% |
| 2013-08-26 | QVT Fund V LP | 1.42M | 7.80% |
| 2013-02-25 | RRC Management, LLC | 600K | 5.10% |
| 2013-02-25 | RRC Bio Fund, L.P. | 600K | 5.10% |
| 2013-02-25 | James A. Silverman | 600K | 5.10% |
| 2013-02-25 | Risk/Reward Capital Management Corp. | 600K | 5.10% |
| 2013-02-15 | Sabby Healthcare Volatility Master Fund, Ltd. | 1.21M | 9.99% |
| 2012-12-20 | Martin Shkreli | 3.38M | 40.54% |
| 2012-12-20 | MSMB Healthcare Management LLC | 473.27K | 5.68% |
| 2012-12-20 | MSMB Capital Management LLC | 375K | 4.50% |
| 2012-12-20 | MSMB Healthcare Investors LLC | 473.69K | 5.68% |
| 2012-12-20 | MSMB Capital Management LP | 375K | 4.50% |
| 2012-12-20 | MSMB Healthcare LP | 473.27K | 5.68% |
TVTX Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $38.21 | 89.21M | $3.41B | $93.04M | $328.73M | $3.64B |
| 2024-12-31 | $17.42 | 78.89M | $1.37B | $58.54M | $401.58M | $1.72B |
| 2023-12-31 | $8.99 | 74.27M | $667.66M | $58.18M | $404.78M | $1.01B |
| 2022-12-31 | $21.03 | 63.76M | $1.34B | $61.69M | $407.49M | $1.69B |
| 2021-12-31 | $31.04 | 59.83M | $1.86B | $165.75M | $261.99M | $1.95B |
| 2020-12-31 | $27.26 | 47.54M | $1.3B | $84.77M | $244.03M | $1.45B |
| 2019-12-31 | $14.20 | 42.34M | $601.23M | $62.44M | $214.87M | $753.66M |
| 2018-12-31 | $22.63 | 40.42M | $914.8M | $102.87M | $217.55M | $1.03B |
| 2017-12-31 | $21.07 | 38.77M | $816.88M | $99.39M | $45.08M | $762.56M |
| 2016-12-31 | $18.93 | 37M | $700.37M | $41M | $44.42M | $703.79M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $29.71 | 91.87M | $2.73B | $78.36M | $327.66M | $2.98B |
| 2025-12-31 | $38.21 | 90.29M | $3.45B | $93.04M | $339.87M | $3.7B |
| 2025-09-30 | $23.90 | 89.23M | $2.13B | $110.93M | $329.75M | $2.35B |
| 2025-06-30 | $14.80 | 88.95M | $1.32B | $75.15M | $399.57M | $1.64B |
| 2025-03-31 | $17.92 | 88.36M | $1.58B | $61.9M | $400.46M | $1.92B |
| 2024-12-31 | $17.42 | 83.1M | $1.45B | $58.54M | $401.58M | $1.79B |
| 2024-09-30 | $13.99 | 77.78M | $1.09B | $36.41M | $402.43M | $1.45B |
| 2024-06-30 | $8.28 | 77.5M | $641.7M | $32.29M | $403.23M | $1.01B |
| 2024-03-31 | $7.31 | 77.14M | $563.87M | $43.25M | $404.02M | $924.63M |
| 2023-12-31 | $8.99 | 76.47M | $687.51M | $58.18M | $404.78M | $1.03B |
| 2023-09-30 | $8.94 | 76.31M | $682.17M | $144.24M | $405.48M | $943.41M |
| 2023-06-30 | $15.36 | 76M | $1.17B | $70.87M | $406.17M | $1.5B |